Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MNOV Medicinova, Inc.
$1.34 -4.29% -0.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MNOV stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Medicinova, Inc. (MNOV)

Loading

Key Stats

Market cap. 68.7M
Enterprise value 42.3M
Trailing PE -5.604166785876
Forward PE -2.7087379
PEG Ratio 0.19614583750566
Enterprise to EBITDA -3.676
Enterprise to revenue 45.221
Price to book MRQ 1.7394015
Price to sales TTM 76.37947

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 935.7K
EBITDA -11512367
Diluted EPS TTM -0.21
Total Cash (MRQ) 29.3M
Current ratio (MRQ) 8.749
Operating Cash Flow (TTM) -9792496

MNOV trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent MNOV News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.